UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 150

Sortiert nach

Fly for ALS: Drosophila modeling on the route to amyotrophic lateral sclerosis modifiers

Cellular and molecular life sciences : CMLS, 2021-09, Vol.78 (17-18), p.6143-6160

2021

Volltextzugriff (PDF)

Machine learning as a new tool in neurological disease prevention, diagnosis, and treatment

Exploration of neuroprotective therapy, 2023-02, Vol.3 (1), p.1-7

Cinzia Volonté

2023

Volltextzugriff (PDF)

Drug Repurposing: A Network-based Approach to Amyotrophic Lateral Sclerosis

Neurotherapeutics, 2021-07, Vol.18 (3), p.1678-1691

2021

Volltextzugriff (PDF)

Further arguments in favor of the biological relevance of purinergic receptors: the novel emergence of a purinergic signature

Exploration of neuroprotective therapy, 2023-11, Vol.3 (6), p.429-434

2023

Volltextzugriff (PDF)

Repurposing Histaminergic Drugs in Multiple Sclerosis

International journal of molecular sciences, 2022-06, Vol.23 (11), p.6347

2022

Volltextzugriff (PDF)

Rethinking purinergic concepts and updating the emerging role of P2X7 and P2X4 in amyotrophic lateral sclerosis

Neuropharmacology, 2022-12, Vol.221, p.109278-109278, Article 109278

2022

Volltextzugriff (PDF)

A deep scream into the future

Lancet neurology, 2022-05, Vol.21 (5), p.416-416

2022

Volltextzugriff (PDF)

Where and Why Modeling Amyotrophic Lateral Sclerosis

International journal of molecular sciences, 2021-04, Vol.22 (8), p.3977

2021

Volltextzugriff (PDF)

A Closer Look at Histamine in Drosophila

International journal of molecular sciences, 2024-04, Vol.25 (8), p.4449

2024

Volltextzugriff (PDF)

Histamine beyond its effects on allergy: Potential therapeutic benefits for the treatment of Amyotrophic Lateral Sclerosis (ALS)

Pharmacology & therapeutics (Oxford), 2019-10, Vol.202, p.120-131

2019

Volltextzugriff (PDF)

P2X7 Receptor in the Management of Energy Homeostasis: Implications for Obesity, Dyslipidemia, and Insulin Resistance

Frontiers in endocrinology (Lausanne), 2020-05, Vol.11, p.199-199

2020

Volltextzugriff (PDF)

Amyotrophic lateral sclerosis disease burden: doing better at getting better

Neural regeneration research, 2023-08, Vol.18 (8), p.1728-1729

2023

Volltextzugriff (PDF)

P2X7 Receptor Activation Modulates Autophagy in SOD1-G93A Mouse Microglia

Frontiers in cellular neuroscience, 2017-08, Vol.11, p.249-249

2017

Volltextzugriff (PDF)

Functional microglia neurotransmitters in amyotrophic lateral sclerosis

Seminars in cell & developmental biology, 2019-10, Vol.94, p.121-128

2019

Volltextzugriff (PDF)

Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression

Journal of neuroinflammation, 2016-08, Vol.13 (1), p.191-191, Article 191

2016

Volltextzugriff (PDF)

Delineating Purinergic Signaling in Drosophila

International journal of molecular sciences, 2022-12, Vol.23 (23), p.15196

2022

Volltextzugriff (PDF)

Clemastine Confers Neuroprotection and Induces an Anti-Inflammatory Phenotype in SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis

Molecular neurobiology, 2016, Vol.53 (1), p.518-531

2016

Volltextzugriff (PDF)

Purinergic contribution to amyotrophic lateral sclerosis

Neuropharmacology, 2016-05, Vol.104, p.180-193

2016

Volltextzugriff (PDF)

Dysregulation of alternative splicing underlies synaptic defects in familial amyotrophic lateral sclerosis

Progress in neurobiology, 2023-12, Vol.231, p.102529-102529, Article 102529

2023

Volltextzugriff (PDF)

P2Y_(12) Receptor on the Verge of a Neuroinflammatory Breakdown

Mediators of Inflammation, 2014-01, Vol.2014 (10), p.975849-975849

2014

Volltextzugriff (PDF)

Modulation of P2X7 Receptor during Inflammation in Multiple Sclerosis

Frontiers in immunology, 2017-11, Vol.8, p.1529-1529

2017

Volltextzugriff (PDF)

P2X7 activation enhances skeletal muscle metabolism and regeneration in SOD1G93A mouse model of amyotrophic lateral sclerosis

Brain pathology (Zurich, Switzerland), 2020-03, Vol.30 (2), p.272-282

2020

Volltextzugriff (PDF)

Duality of P2X7 Receptor in Amyotrophic Lateral Sclerosis

Frontiers in pharmacology, 2020-07, Vol.11, p.1148-1148

2020

Volltextzugriff (PDF)

M1 and M2 Functional Imprinting of Primary Microglia: Role of P2X7 Activation and miR-125b

Mediators of Inflammation, 2016-01, Vol.2016, p.2989548-9

2016

Volltextzugriff (PDF)

S100B Protein as a Therapeutic Target in Multiple Sclerosis: The S100B Inhibitor Arundic Acid Protects from Chronic Experimental Autoimmune Encephalomyelitis

International journal of molecular sciences, 2021-12, Vol.22 (24), p.13558

2021

Volltextzugriff (PDF)

1 – 25 von 150

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(136)

Publikationsform

Artikel
(148)
Buchkapitel
(2)

Sprache

Englisch
(150)
Japanisch
(19)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(94)
Life Sciences & Biomedicine
(93)
Animals
(79)
Neurosciences
(49)
Neurosciences & Neurology
(46)
Humans
(45)
Rats
(38)
Biochemistry & Molecular Biology
(33)
Biological And Medical Sciences
(29)
Cell Biology
(24)
Fundamental And Applied Biological Sciences. Psychology
(24)
Amyotrophic Lateral Sclerosis
(23)
Cells, Cultured
(21)
Mice
(20)
Rats, Wistar
(20)
Receptors, Purinergic P2 - Metabolism
(18)
Disease Models, Animal
(17)
Microglia
(16)
Amyotrophic Lateral Sclerosis - Metabolism
(15)
Inflammation
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Fly for ALS: Drosophila modeling on the route to amyotrophic lateral sclerosis modifiers

Machine learning as a new tool in neurological disease prevention, diagnosis, and treatment

Drug Repurposing: A Network-based Approach to Amyotrophic Lateral Sclerosis

Further arguments in favor of the biological relevance of purinergic receptors: the novel emergence of a purinergic signature

Repurposing Histaminergic Drugs in Multiple Sclerosis

Rethinking purinergic concepts and updating the emerging role of P2X7 and P2X4 in amyotrophic lateral sclerosis

A deep scream into the future

Where and Why Modeling Amyotrophic Lateral Sclerosis

A Closer Look at Histamine in Drosophila

Histamine beyond its effects on allergy: Potential therapeutic benefits for the treatment of Amyotrophic Lateral Sclerosis (ALS)

P2X7 Receptor in the Management of Energy Homeostasis: Implications for Obesity, Dyslipidemia, and Insulin Resistance

Amyotrophic lateral sclerosis disease burden: doing better at getting better

P2X7 Receptor Activation Modulates Autophagy in SOD1-G93A Mouse Microglia

Functional microglia neurotransmitters in amyotrophic lateral sclerosis

Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression

Delineating Purinergic Signaling in Drosophila

Clemastine Confers Neuroprotection and Induces an Anti-Inflammatory Phenotype in SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis

Purinergic contribution to amyotrophic lateral sclerosis

Dysregulation of alternative splicing underlies synaptic defects in familial amyotrophic lateral sclerosis

P2Y_(12) Receptor on the Verge of a Neuroinflammatory Breakdown

Modulation of P2X7 Receptor during Inflammation in Multiple Sclerosis

P2X7 activation enhances skeletal muscle metabolism and regeneration in SOD1G93A mouse model of amyotrophic lateral sclerosis

Duality of P2X7 Receptor in Amyotrophic Lateral Sclerosis

M1 and M2 Functional Imprinting of Primary Microglia: Role of P2X7 Activation and miR-125b

S100B Protein as a Therapeutic Target in Multiple Sclerosis: The S100B Inhibitor Arundic Acid Protects from Chronic Experimental Autoimmune Encephalomyelitis

Suchergebnisse filtern